Ashton Thomas Private Wealth LLC Has $752,000 Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Ashton Thomas Private Wealth LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,883 shares of the biotechnology company’s stock after purchasing an additional 53 shares during the quarter. Ashton Thomas Private Wealth LLC’s holdings in Axon Enterprise were worth $752,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of AXON. Blue Trust Inc. boosted its position in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC lifted its holdings in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares in the last quarter. Asset Dedication LLC acquired a new position in Axon Enterprise in the second quarter valued at about $47,000. Friedenthal Financial bought a new stake in shares of Axon Enterprise in the third quarter worth about $51,000. Finally, Cullen Frost Bankers Inc. acquired a new stake in shares of Axon Enterprise during the second quarter worth about $59,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $601.29 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a 50 day moving average price of $428.90 and a 200 day moving average price of $353.54. The stock has a market capitalization of $45.85 billion, a PE ratio of 155.37, a price-to-earnings-growth ratio of 14.95 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $220.51 and a 52 week high of $624.84.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective on the stock. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, JMP Securities lifted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Insider Activity

In related news, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the sale, the director now directly owns 7,379 shares in the company, valued at approximately $2,752,588.37. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 389,172 shares of company stock valued at $148,393,842. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.